CN1554408A - Medicine for lowering blood lipid and softening blood vessel and its preparing method - Google Patents
Medicine for lowering blood lipid and softening blood vessel and its preparing method Download PDFInfo
- Publication number
- CN1554408A CN1554408A CNA2003101193732A CN200310119373A CN1554408A CN 1554408 A CN1554408 A CN 1554408A CN A2003101193732 A CNA2003101193732 A CN A2003101193732A CN 200310119373 A CN200310119373 A CN 200310119373A CN 1554408 A CN1554408 A CN 1554408A
- Authority
- CN
- China
- Prior art keywords
- parts
- blood fat
- fat reducing
- vessel softening
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008280 blood Substances 0.000 title claims abstract description 56
- 210000004369 blood Anatomy 0.000 title claims abstract description 56
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 150000002632 lipids Chemical class 0.000 title abstract description 4
- 210000004204 blood vessel Anatomy 0.000 title abstract 2
- 238000000034 method Methods 0.000 title description 6
- 229940079593 drug Drugs 0.000 title description 4
- 210000000582 semen Anatomy 0.000 claims description 22
- 238000001035 drying Methods 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 239000000843 powder Substances 0.000 claims description 18
- 239000000284 extract Substances 0.000 claims description 16
- 239000008187 granular material Substances 0.000 claims description 15
- 206010013786 Dry skin Diseases 0.000 claims description 12
- 230000006837 decompression Effects 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 238000010992 reflux Methods 0.000 claims description 12
- 238000005303 weighing Methods 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 238000005469 granulation Methods 0.000 claims description 9
- 230000003179 granulation Effects 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 239000000796 flavoring agent Substances 0.000 claims description 5
- 235000019634 flavors Nutrition 0.000 claims description 5
- 235000012907 honey Nutrition 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 239000007901 soft capsule Substances 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 239000007902 hard capsule Substances 0.000 claims description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 3
- 240000008415 Lactuca sativa Species 0.000 claims description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 239000007766 cera flava Substances 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 239000000084 colloidal system Substances 0.000 claims description 3
- 230000001804 emulsifying effect Effects 0.000 claims description 3
- 235000010445 lecithin Nutrition 0.000 claims description 3
- 239000000787 lecithin Substances 0.000 claims description 3
- 229940067606 lecithin Drugs 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 3
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 235000012045 salad Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 23
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract description 4
- 206010003119 arrhythmia Diseases 0.000 abstract description 3
- 230000006793 arrhythmia Effects 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 210000004165 myocardium Anatomy 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- TYYDXNISHGVDGA-UHFFFAOYSA-N Corotoxigenin Natural products CC12CCC3C(CCC4CC(O)CCC34C=O)C1CCC2C5=CC(=O)OC5 TYYDXNISHGVDGA-UHFFFAOYSA-N 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- JIUWTCXNUNHEGP-GJHPUSIBSA-N cardenolide Chemical compound C1([C@H]2CC[C@@H]3[C@H]4[C@@H]([C@]5(CCCCC5CC4)C)CC[C@@]32C)=CC(=O)OC1 JIUWTCXNUNHEGP-GJHPUSIBSA-N 0.000 abstract 1
- 210000004351 coronary vessel Anatomy 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 238000003809 water extraction Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 239000008588 xue-zhi-ning Substances 0.000 description 14
- 230000001225 therapeutic effect Effects 0.000 description 8
- 208000031226 Hyperlipidaemia Diseases 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 208000029078 coronary artery disease Diseases 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 230000003177 cardiotonic effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000003516 hyperlipidaemic effect Effects 0.000 description 1
- 208000020346 hyperlipoproteinemia Diseases 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000023482 precordial pain Diseases 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The medicine is prepared with four kinds of Chinese medicinal materials including cassia seed, haw, lotus leaf and prepared fleeceflower root in certain proportion, and through water extraction, crushing and other steps. The medicine has obvious curative effect of lowering blood lipid, softening blood vessels, strengthening the blood circulation of coronary artery and raising the sensitivity of cardiac muscle on cardenolide in treating arrhythmia and hyperlipemia.
Description
Technical field
The present invention relates to blood fat reducing, vessel softening, be used to strengthen blood circulation coronarius, improve the sensitivity of cardiac muscle, medicine of a kind of blood fat reducing vessel softening of arrhythmia and hyperlipidemia and preparation method thereof the cardiotonic glycoside effect.
Technical background
The research work of using the treatment by Chinese herbs hyperlipidemia in recent years grows a lot, the research data of Chinese medicine blood fat reducing has a lot, mainly contain periodical Tianjin traditional Chinese medical science nineteen ninety, (4) document serial number 92002669 discloses " clinical observation on the therapeutic effect of Chinese medicine fat reducing pill treatment hyperlipoproteinemia " its prescription: Fructus Crataegi 100g, Semen Cassiae, Folium Nelumbinis, the Radix Polygoni Multiflori, Radix Salviae Miltiorrhizae, each 60g medicine-feeding of Rhizoma Alismatis are fine flour altogether, practicing honey is ball, through 103 routine hyperlipemic patients checkings, total effective rate 89.22%.But its component flavour of a drug are more, the cost height.
Summary of the invention:
The object of the present invention is to provide through clinical verification evident in efficacy with medicine existing prescription component, a kind of blood fat reducing vessel softening that proportioning is different and preparation method thereof.Reduce component and reduce cost, the present invention takes following technical scheme for this reason: a kind of medicine of blood fat reducing vessel softening is characterized in that it is the medicament that the following weight proportion raw material is made:
700 parts-850 parts of 30 portions of-45 portions of Fructus Crataegis of Semen Cassiae
30 parts-45 parts of 100 parts of-130 parts of Radix Polygoni Multiflori Preparatas of Folium Nelumbinis
According to the medicine of above-mentioned blood fat reducing vessel softening, it is characterized in that its best proportioning is:
800 parts of 40 portions of Fructus Crataegis of Semen Cassiae
40 parts of 120 parts of Radix Polygoni Multiflori Preparatas of Folium Nelumbinis
According to the medicine of above-mentioned blood fat reducing vessel softening, it is characterized in that said medicament is the above a dosage form of any pharmaceutics.
According to the medicine of described blood fat reducing vessel softening, it is characterized in that said medicament is pill, capsule, tablet, granule.
According to the process for preparing medicine of described blood fat reducing, vessel softening, it is characterized in that above four flavors, add 480 parts of white sugar, be ground into fine powder 100 orders that sieve, mixing; In the GMP cleaning shop, above-mentioned raw materials is mixed in proportion, add 1036-1332 part refined honey, make blood fat reducing, vessel softening honeyed pill.
According to the process for preparing medicine of described blood fat reducing vessel softening, it is characterized in that taking by weighing Semen Cassiae, Fructus Crataegi, Radix Polygoni Multiflori Preparata, Folium Nelumbinis and add 10 times of water gagings, reflux, extract, 2 times, each 2 hours, filter, when filtrate decompression is concentrated into 80 ℃ of thick paste shapes, relative density is 1.28, and is standby; The water of said extracted gained is carried thick paste, and 50～60 ℃ of drying under reduced pressure were pulverized 100 mesh sieves and were got fine powder.Use 70% alcohol granulation, cross 18 mesh sieves, 50～60 ℃ of dryings are crossed 18 mesh sieve granulate, and the hard capsule of packing into promptly gets blood fat reducing, vessel softening capsule.
According to the process for preparing medicine of described blood fat reducing vessel softening, it is characterized in that taking by weighing Semen Cassiae, Fructus Crataegi, Radix Polygoni Multiflori Preparata, Folium Nelumbinis and add 10 times of water gagings, reflux, extract, 2 times, each 2 hours, filter, when filtrate decompression is concentrated into 80 ℃ of thick paste shapes, relative density is 1.28, and is standby; The water of said extracted gained is carried thick paste, and 50～60 ℃ of drying under reduced pressure were pulverized 100 mesh sieves and were got fine powder.Use 65% alcohol granulation, cross 18 mesh sieves, 50～60 ℃ of dryings are crossed 18 mesh sieve granulate, promptly get blood fat reducing, vessel softening granule.
According to the preparation method of the medicine of described blood fat reducing vessel softening, it is characterized in that taking by weighing Semen Cassiae, Fructus Crataegi, Radix Polygoni Multiflori Preparata, Folium Nelumbinis and add 10 times of water gagings, reflux, extract, 2 times, each 2 hours, filter, when filtrate decompression is concentrated into 80 ℃ of thick paste shapes, relative density is 1.28, and is standby; The water of said extracted gained is carried thick paste, add 80 parts of starch, 100 parts of microcrystalline Cellulose, mixing, 50～60 ℃ of dryings were pulverized 100 mesh sieves and were got fine powder, added CMC-Ca30 part, mixing is used 70% alcohol granulation, crosses 18 mesh sieves, 50～60 ℃ of dryings, cross 18 mesh sieve granulate, add 4 parts of magnesium stearate, mixing, tabletting promptly gets blood fat reducing vessel softening sheet.
Preparation method according to the medicine of described blood fat reducing vessel softening, it is characterized in that taking by weighing Semen Cassiae, Fructus Crataegi, Radix Polygoni Multiflori Preparata, Folium Nelumbinis and add 10 times of water gagings, reflux, extract, 2 times, each 2 hours, filter, when filtrate decompression is concentrated into 80 ℃ of thick paste shapes, relative density is 1.28, drying under reduced pressure was pulverized 100 mesh sieves and got fine powder, and was standby; To stir evenly after 0.5 part in lecithin, 500 parts of salad oils, 60 parts of heat fused of Cera Flava, filter, add medicated powder when being cooled to 40 ℃, emulsifying is also crossed colloid mill, makes blood fat reducing, vessel softening soft capsule.
Through Tianjin peace hospital, Tianjin waterside pavilion hospital, "four news" (new ideas cotton mill, Tianjin health station, Tangshan City's pottery hospital, hospital of Langfang petroleum pipeline office blood fat reducing vessel softening ball (claiming XUEZHINING WAN again) is done clinical 250 routine curative effect statistics altogether by 250 routine clinical trial XUEZHINING from 1980 to 1981 and sees Table 1:
Table 1
| Organization | The example number | Produce effects | Percentage ratio | Effectively | Percentage ratio | Invalid | Percentage ratio |
| Tianjin peace hospital | ????44 | ????25 | ????57％ | ????12 | ????27％ | ????7 | ????16％ |
| Tianjin waterside pavilion hospital | ????85 | ????47 | ????55％ | ????35 | ????41％ | ????3 | ?????4％ |
| "four news" (new ideas cotton mill, Tianjin health station | ?????8 | ?????3 | ??37.5％ | ?????4 | ????50％ | ????1 | ??12.5％ |
| Tangshan City pottery hospital | ????20 | ?????5 | ????25％ | ????11 | ????55％ | ????4 | ????20％ |
| Tangshan City first hospital | ????31 | ????21 | ????68％ | ?????7 | ????22％ | ????3 | ????10％ |
| Langfang hospital of petroleum pipeline office | ????62 | ????35 | ????56％ | ????18 | ????29％ | ????9 | ????15％ |
| Amount to | ???250 | ???136 | ??54.4％ | ????87 | ??34.8％ | ???27 | ??10.8％ |
Find out 250 routine total effective rates 89.2% from table, test shows, evident in efficacy treatment cholesterol, triglyceride disease, it is a kind of determined curative effect, easy to carry be used to strengthen blood circulation coronarius, improve the sensitivity of cardiac muscle the cardiotonic glycoside effect, arrhythmia and hyperlipidemia Chinese medicine preparation, the few two flavor medicines of relatively existing prescription reduce cost and have guaranteed the higher effective rate.
Enumerate " peaceful hospital XUEZHINING observation of curative effect material " that peace hospital in Tianjin does totally 44 examples here, see Table 2:
Table 2
| Curative effect | The example number | Percentage ratio | Remarks |
| Produce effects | ??25 | ???57％ | |
| Effectively | ??12 | ???27％ | |
| Invalid | ???7 | ???16％ | |
| Amount to | ??44 | ??100％ |
Find out 44 routine total effective rates 84% from table.XUEZHINING treatment hyperlipidemia 44 routine clinical observation on the therapeutic effect: coronary heart disease is a kind of common frdquently encountered disease, and its pathogenic factor is more, but wherein one of chief reason and related to blood fat.We obtain preliminary effect from year February in March, 1980 to 1981 with XUEZHINING treatment hyperlipidemia 44 examples, now the clinical observation on the therapeutic effect result are reported as follows:
One, physical data:
Among the 44 routine patients, male's 26 examples, women's 18 examples, minimum 21 years old of age, the oldest 70 years old, the mean age 48, the year, the cadre accounts for 27 people, workman 16 people, housewife 1 people, coronary heart disease 16 people, coronary heart disease of hypertension 9 people, hyperlipidemia 17 people, chronic hepatitis 1 people.
Two, prescription is formed and method of administration:
XUEZHINING Main Ingredients and Appearance: refined honey balls such as Fructus Crataegi, the Radix Polygoni Multiflori, Folium Nelumbinis, white sugar, the heavy 4.5g of every ball obeys secondary every day, obeys 4 balls at every turn, at period in a medicine, withdraw in other, western lipid lowerers, diet is as usual, take medicine before the chemical examination blood fat, so that in contrast, every clothes one month were a course of treatment, and the check blood fat is once observed contrast before and after taking medicine.
Three, therapeutic evaluation standard:
I chemically examine normal value, cholesterol peak 220mg% by institute's blood fat.
(example) what * *, the woman, 54 years old, for my nurse of institute (retirement) has high blood at ordinary times
Press, press coronary heart disease, main suit's dizziness, feel suffocated, precordial pain, what on October 13rd, 80 began to take XUEZHINING, in the preceding chemical examination of taking medicine: three acid glycerol 1000mg%, take medicine and chemically examine after January: three acid glycerol 365mg%, chemical examination after taking medicine two months: it is a lot of that three acid glycerol 500mg%, (during this period because of having eaten the food of some chickens, shrimp and so on) but the inferior medicine of clothes generally speaking descend, and symptom significantly alleviates.
(example) Lee * *, man, 47 years old, work unit: peaceful hospital, professional laboratorian, main suit's dizziness, hands swelling, chemical examination: three acid glycerol 170mg%, chemical examination three acid glycerol 95mg% after the January of taking medicine, dizzy, hands swelling transference cure.Period in a medicine is not obeyed in other, western lipid lowerers.
Below be that 44 examples are taken XUEZHINING therapeutic effect statistical table 3
Table 3 is that 44 examples are taken XUEZHINING therapeutic effect statistics
| Sequence number | The example number | Cholesterol decline effect number | The example number | Triglyceride decline effect number | ||||||
| Produce effects | Effectively | Invalid | Decline % | Produce effects | Effectively | Invalid | Decline % | |||
| ????1 | ??23 | ????13 | ????4 | ????6 | ????74 | ??26 | ????13 | ????6 | ????7 | ????73 |
| ????2 | ??16 | ????2 | ????14 | ????100 | ??14 | ????13 | ????1 | ????100 | ||
| ????3 | ??3 | ????1 | ????2 | ????33 | ??2 | ????1 | ????1 | ????50 | ||
| ????4 | ??1 | ????1 | ????- | ??1 | ????1 | |||||
| ????5 | ??1 | ????1 | ????- | ??1 | ????1 | |||||
| Amount to | ??44 | ????16 | ????18 | ????10 | ????77 | ??44 | ????27 | ????7 | ????10 | ????77 |
Four, side effect: oral non-evident effect, have only a few patients reaction that gastric acid is arranged, still advise all have serious gastric ulcer patient Ying Shen with or need not.The routine number that we observe is less, and the time is shorter, from the observation of curative effect that 44 routine patients take medicine, thinks that XUEZHINING treatment hyperlipemia curative effect is a medicine preferably, and lipid-lowering effect is more remarkable.If allow patient eat the food of increase blood fat less at period in a medicine, the effect of blood fat reducing can be better.Good than other fat-reducing medicament lipid-lowering effects, it is fast to produce effects, and has no side effect, so suggestion is put into operation.
Other clinical datas in 250 examples see attached Tianjin waterside pavilion hospital " XUEZHINING treatment hyperlipemia 85 routine observation of curative effect " for details; "four news" (new ideas cotton mill, Tianjin health station " XUEZHINING clinical observation on the therapeutic effect table (8) example "; Tangshan City pottery hospital's " XUEZHINING 20 routine clinical observations "; Tangshan City first hospital " 31 routine clinical observation on the therapeutic effect "; Hospital of pipeline office of Langfang petroleum department " XUEZHINING treatment hyperlipemia 50 routine clinical observation efficacy analysis ".
Description of drawings
Fig. 1 is a blood fat reducing vessel softening ball process chart.
Fig. 2 is a blood fat reducing vessel softening hard capsule process chart.
Fig. 3 is a blood fat reducing vessel softening granule process chart.
Fig. 4 is a blood fat reducing vessel softening blade technolgy flow chart.
Fig. 5 is a blood fat reducing vessel softening soft capsule process chart.
The specific embodiment
The preparation of embodiment 1 blood fat reducing vessel softening ball:
Prescription:
800 parts of 40 portions of Fructus Crataegis of Semen Cassiae
40 parts of 120 parts of Radix Polygoni Multiflori Preparatas of Folium Nelumbinis
Preparation method:
More than four flavors, add 480 parts of white sugar, be ground into fine powder 100 orders that sieve, mixing.
In the GMP cleaning shop, above-mentioned raw materials is mixed in proportion, add 1036-1332 part refined honey, make the big honeyed pills of the heavy 9g of every ball.
The preparation of embodiment 2 blood fat reducing vessel softening hard capsules:
Prescription:
800 parts of 40 portions of Fructus Crataegis of Semen Cassiae
40 parts of 120 parts of Radix Polygoni Multiflori Preparatas of Folium Nelumbinis
Preparation method:
One: extract
Take by weighing Semen Cassiae, Fructus Crataegi, Radix Polygoni Multiflori Preparata, Folium Nelumbinis and add 10 times of water gagings, reflux, extract, 2 times, each 2 hours, filter, filtrate decompression is concentrated into thick paste shape (80 ℃ time, relative density is 1.28), and is standby.
Two: preparation
The water of said extracted gained is carried thick paste, and 50～60 ℃ of drying under reduced pressure were pulverized 100 mesh sieves and were got fine powder.Use 70% alcohol granulation, cross 18 mesh sieves, 50～60 ℃ of dryings are crossed 18 mesh sieve granulate, and encapsulated (tolerant 0.33 gram of every intragranular), promptly.
The particulate preparation of embodiment 3 blood fat reducing vessel softeninges:
Prescription:
800 parts of 40 portions of Fructus Crataegis of Semen Cassiae
40 parts of 120 parts of Radix Polygoni Multiflori Preparatas of Folium Nelumbinis
Preparation method:
One: extract
Take by weighing Semen Cassiae, Fructus Crataegi, Radix Polygoni Multiflori Preparata, Folium Nelumbinis and add 10 times of water gagings, reflux, extract, 2 times, each 2 hours, to filter, filtrate decompression is concentrated into thick paste shape (80 ℃ time, relative density is 1.28), and is standby.
Two: preparation
The water of said extracted gained is carried thick paste, and 50～60 ℃ of drying under reduced pressure were pulverized 100 mesh sieves and were got fine powder.Use 65% alcohol granulation, cross 18 mesh sieves, 50～60 ℃ of dryings are crossed 18 mesh sieve granulate, promptly get blood fat reducing vessel softening granule.
The preparation of embodiment 4 blood fat reducing vessel softening sheets:
Prescription:
800 parts of 40 portions of Fructus Crataegis of Semen Cassiae
40 parts of 120 parts of Radix Polygoni Multiflori Preparatas of Folium Nelumbinis
Preparation method:
One: extract
Take by weighing Semen Cassiae, Fructus Crataegi, Radix Polygoni Multiflori Preparata, Folium Nelumbinis and add 10 times of water gagings, reflux, extract, 2 times, each 2 hours, to filter, filtrate decompression is concentrated into thick paste shape (80 ℃ time, relative density is 1.28), and is standby.
Two: preparation
The water of said extracted gained is carried thick paste, add 80 parts of starch, 100 parts of microcrystalline Cellulose, mixing, 50～60 ℃ of dryings were pulverized 100 mesh sieves and were got fine powder, added CMC-Ca30 part, mixing is used 70% alcohol granulation, crosses 18 mesh sieves, 50～60 ℃ of dryings, cross 18 mesh sieve granulate, add 4 parts of magnesium stearate, mixing, tabletting (every 0.33 gram) promptly gets blood fat reducing vessel softening sheet.
Embodiment 4 blood fat reducing vessel softening preparation of soft capsule:
Prescription:
800 parts of 40 portions of Fructus Crataegis of Semen Cassiae
40 parts of 120 parts of Radix Polygoni Multiflori Preparatas of Folium Nelumbinis
Preparation method:
One: extract
Take by weighing Semen Cassiae, Fructus Crataegi, Radix Polygoni Multiflori Preparata, Folium Nelumbinis and add 10 times of water gagings, reflux, extract, 2 times, each 2 hours, to filter, filtrate decompression is concentrated into thick paste shape (80 ℃ time, relative density is 1.28), and drying under reduced pressure was pulverized 100 mesh sieves and got fine powder, and was standby.
Two: preparation
To stir evenly after 0.5 part in lecithin, 500 parts of salad oils, 60 parts of heat fused of Cera Flava, filter, add medicated powder when being cooled to 40 ℃, emulsifying is also crossed colloid mill, makes blood fat reducing vessel softening soft capsule (every 0.5g).
Claims (9)
1, a kind of medicine of blood fat reducing vessel softening is characterized in that it is the medicament that the following weight proportion raw material is made:
700 parts-850 parts of 30 portions of-45 portions of Fructus Crataegis of Semen Cassiae
30 parts-45 parts of 100 parts of-130 parts of Radix Polygoni Multiflori Preparatas of Folium Nelumbinis
2,, it is characterized in that its best proportioning is according to the medicine of the described blood fat reducing vessel softening of claim 1:
800 parts of 40 portions of Fructus Crataegis of Semen Cassiae
40 parts of 120 parts of Radix Polygoni Multiflori Preparatas of Folium Nelumbinis
3, the medicine of blood fat reducing vessel softening according to claim 1 and 2 is characterized in that said medicament is the above a dosage form of any pharmaceutics.
4, the medicine of blood fat reducing vessel softening according to claim 3 is characterized in that said medicament is pill, capsule, tablet, granule.
5, the process for preparing medicine of blood fat reducing vessel softening according to claim 4 is characterized in that above four flavors, adds 480 parts of white sugar, is ground into fine powder 100 orders that sieve, mixing; In the GMP cleaning shop, above-mentioned raw materials is mixed in proportion, add 1036-1332 part refined honey, make blood fat reducing, vessel softening honeyed pill.
6, the process for preparing medicine of blood fat reducing vessel softening according to claim 4, it is characterized in that taking by weighing Semen Cassiae, Fructus Crataegi, Radix Polygoni Multiflori Preparata, Folium Nelumbinis and add 10 times of water gagings, reflux, extract, 2 times, each 2 hours, filter, when filtrate decompression was concentrated into 80 ℃ of thick paste shapes, relative density is 1.28, and was standby; The water of said extracted gained is carried thick paste, and 50～60 ℃ of drying under reduced pressure were pulverized 100 mesh sieves and were got fine powder.Use 70% alcohol granulation, cross 18 mesh sieves, 50～60 ℃ of dryings are crossed 18 mesh sieve granulate, and the hard capsule of packing into promptly gets blood fat reducing vessel softening capsule.
7, the process for preparing medicine of blood fat reducing vessel softening according to claim 1 and 2, it is characterized in that taking by weighing Semen Cassiae, Fructus Crataegi, Radix Polygoni Multiflori Preparata, Folium Nelumbinis and add 10 times of water gagings, reflux, extract, 2 times, each 2 hours, filter, when filtrate decompression was concentrated into 80 ℃ of thick paste shapes, relative density is 1.28, and was standby; The water of said extracted gained is carried thick paste, and 50～60 ℃ of drying under reduced pressure were pulverized 100 mesh sieves and were got fine powder; Use 65% alcohol granulation, cross 18 mesh sieves, 50～60 ℃ of dryings are crossed 18 mesh sieve granulate, promptly get blood fat reducing vessel softening granule.
8, the process for preparing medicine of blood fat reducing vessel softening according to claim 4, it is characterized in that taking by weighing Semen Cassiae, Fructus Crataegi, Radix Polygoni Multiflori Preparata, Folium Nelumbinis and add 10 times of water gagings, reflux, extract, 2 times, each 2 hours, filter, when filtrate decompression was concentrated into 80 ℃ of thick paste shapes, relative density is 1.28, and was standby; The water of said extracted gained is carried thick paste, add 80 parts of starch, 100 parts of microcrystalline Cellulose, mixing, 50～60 ℃ of dryings were pulverized 100 mesh sieves and were got fine powder, added CMC-Ca30 part, mixing is used 70% alcohol granulation, crosses 18 mesh sieves, 50～60 ℃ of dryings, cross 18 mesh sieve granulate, add 4 parts of magnesium stearate, mixing, tabletting promptly gets blood fat reducing vessel softening sheet.
9, the process for preparing medicine of blood fat reducing vessel softening according to claim 4, it is characterized in that taking by weighing Semen Cassiae, Fructus Crataegi, Radix Polygoni Multiflori Preparata, Folium Nelumbinis and add 10 times of water gagings, reflux, extract, 2 times, each 2 hours, filter, when filtrate decompression is concentrated into 80 ℃ of thick paste shapes, relative density is 1.28, drying under reduced pressure was pulverized 100 mesh sieves and got fine powder, and was standby; To stir evenly after 0.5 part in lecithin, 500 parts of salad oils, 60 parts of heat fused of Cera Flava, filter, add medicated powder when being cooled to 40 ℃, emulsifying is also crossed colloid mill, makes blood fat reducing vessel softening soft capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200310119373 CN1289111C (en) | 2003-12-23 | 2003-12-23 | Medicine for lowering blood lipid and softening blood vessel and its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200310119373 CN1289111C (en) | 2003-12-23 | 2003-12-23 | Medicine for lowering blood lipid and softening blood vessel and its preparing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1554408A true CN1554408A (en) | 2004-12-15 |
| CN1289111C CN1289111C (en) | 2006-12-13 |
Family
ID=34338231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200310119373 Expired - Lifetime CN1289111C (en) | 2003-12-23 | 2003-12-23 | Medicine for lowering blood lipid and softening blood vessel and its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1289111C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101653496B (en) * | 2009-09-09 | 2012-05-23 | 天津中新药业集团股份有限公司达仁堂制药厂 | Discrimination method of traditional Chinese medicine Xuezhining pill |
| CN104082748A (en) * | 2014-07-23 | 2014-10-08 | 凯泽（武汉）健康管理有限公司 | Functional food for conditioning lipid balance |
| CN104173495A (en) * | 2014-08-01 | 2014-12-03 | 通化新东日药业股份有限公司 | Jiangzhining granule and preparation method thereof |
| CN117180340A (en) * | 2023-11-08 | 2023-12-08 | 吉林华康食元生物科技有限公司 | Composition for reducing blood fat and preparation method and application thereof |
-
2003
- 2003-12-23 CN CN 200310119373 patent/CN1289111C/en not_active Expired - Lifetime
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101653496B (en) * | 2009-09-09 | 2012-05-23 | 天津中新药业集团股份有限公司达仁堂制药厂 | Discrimination method of traditional Chinese medicine Xuezhining pill |
| CN104082748A (en) * | 2014-07-23 | 2014-10-08 | 凯泽（武汉）健康管理有限公司 | Functional food for conditioning lipid balance |
| CN104173495A (en) * | 2014-08-01 | 2014-12-03 | 通化新东日药业股份有限公司 | Jiangzhining granule and preparation method thereof |
| CN117180340A (en) * | 2023-11-08 | 2023-12-08 | 吉林华康食元生物科技有限公司 | Composition for reducing blood fat and preparation method and application thereof |
| CN117180340B (en) * | 2023-11-08 | 2024-04-26 | 吉林华康食元生物科技有限公司 | Composition for reducing blood fat and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1289111C (en) | 2006-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1840128A (en) | Medicine for treating cardiovascular disease | |
| CN1915399A (en) | Preparation for treating high blood pressure, high blood fat, obesity, and climacteric syndrome, and preparation method | |
| CN106362020B (en) | A kind of pine pollen composition and preparation method thereof with improvement defecating feces excretion | |
| CN101037651A (en) | Lucidum mushroom health wine and production method thereof | |
| CN1813819A (en) | Hedgehog hydnum fruiting body or hyphostroma and culture extract and formulation and preparing method | |
| CN1289111C (en) | Medicine for lowering blood lipid and softening blood vessel and its preparing method | |
| CN102091268A (en) | Medicament for treating allergic rhinitis and preparation method thereof | |
| CN102961584A (en) | Traditional Chinese medicine composition capable of relieving fatigue, as well as preparation method and application thereof | |
| CN1814214A (en) | Chinese medicine composition for treating body thin and delicate coustitution, and preparing method | |
| CN103054952A (en) | Medicine for treating periodontitis and preparation method thereof | |
| CN1990033A (en) | Drug for treating hypertension, dense blood and arteriosclerosis | |
| CN1259095C (en) | Brain-quieting hypertension-treating medicine, and its preparing method and use | |
| CN102697937A (en) | Medicine for treating dental ulcer and preparation method for same | |
| CN102626510A (en) | Traditional Chinese medicine composite for treating diabetic cardiopathy and preparation method and applications of traditional Chinese medicine composite | |
| CN102139057B (en) | Healthcare tea capable of lowering glucose | |
| CN1872186A (en) | Compound capsule of Chinese date kernel, and preparation method | |
| CN101032524A (en) | Application of martianus dermestoides in producing oxygen-deficient resisting medicine or healthy food and the preparing method | |
| CN1045892C (en) | Chinese medicine Guanxintong for preventing and curing coronary heart disease and angina pectoris, and producing process thereof | |
| CN100339119C (en) | Traditional Chinese medicine prepns. for treating diabete | |
| CN1063077C (en) | Traditional Chinese medicine composition for lowering blood-lipid, and method for preparing same | |
| CN1261156C (en) | Medicine for treating chronic gastroenteritis and colitis | |
| CN102698056A (en) | Medicine for treating tinea pedis and preparation method thereof | |
| CN102670809A (en) | Drug for curing pharyngitis and preparing method thereof | |
| CN111000962B (en) | Chinese patent medicine for treating functional dyspepsia of spleen deficiency and damp stagnation syndrome and preparation method thereof | |
| CN100339093C (en) | Compound medicine for treating coronary heart disease and angina pectoris and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CP03 | Change of name, title or address |
Address after: No.21, 10th Street, Binhai New Area Development Zone, Tianjin 300457 Patentee after: Jinyao Darentang Group Co., Ltd. Darentang Pharmaceutical Factory Address before: 300142 No. 330, Hebei District, Tianjin, Zhongshan Road Patentee before: DARENTANG PHARMACEUTICAL FACTORY, TIANJIN ZHONGXIN PHARMACEUTICAL GROUP Co.,Ltd. |
|
| CP03 | Change of name, title or address | ||
| CX01 | Expiry of patent term |
Granted publication date: 20061213 |
|
| CX01 | Expiry of patent term |